| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.09 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.09 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.064 | 0.09 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.1 | 0.1 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |